{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:27:31Z","timestamp":1790836051803,"version":"4.1.0"},"reference-count":79,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1253\/circj.cj-16-0971","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T22:09:45Z","timestamp":1483740585000},"page":"290-297","source":"Crossref","is-referenced-by-count":31,"title":["The Brugada Syndrome\u3000\u2015 From Gene to Therapy \u2015"],"prefix":"10.1253","volume":"81","author":[{"given":"Antonio","family":"Curcio","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medical and Surgical Sciences, University Magna Graecia, Campus di Germaneto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Santarpia","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medical and Surgical Sciences, University Magna Graecia, Campus di Germaneto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medical and Surgical Sciences, University Magna Graecia, Campus di Germaneto"},{"name":"U.R.T. of C.N.R.-I.F.C."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart disease. <i>Circulation<\/i> 1998; 97: 457\u2013460.","DOI":"10.1161\/01.CIR.97.5.457"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. <i>Europace<\/i> 2013; 15: 1389\u20131406.","DOI":"10.1093\/europace\/eut272"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, et al. J-wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. <i>Heart Rhythm<\/i> 2016; 13: e295\u2013e324.","DOI":"10.1016\/j.hrthm.2016.05.024"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R, et al. Ventricular fibrillation without apparent heart disease: Description of six cases. <i>Am Heart J<\/i> 1989; 118: 1203\u20131209.","DOI":"10.1016\/0002-8703(89)90011-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report. <i>J Am Coll Cardiol<\/i> 1992; 20: 1391\u20131396.","DOI":"10.1016\/0735-1097(92)90253-J"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. <i>J Am Coll Cardiol<\/i> 1996; 27: 1061\u20131070.","DOI":"10.1016\/0735-1097(95)00613-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Brugada J, Brugada P. Further characterization of the syndrome of right bundle branch block, persistent ST-segment elevation, and sudden cardiac death. <i>J Cardiovasc Electrophysiol<\/i> 1997; 8: 325\u2013331.","DOI":"10.1111\/j.1540-8167.1997.tb00796.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Brignole M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. <i>Circulation<\/i> 2000; 102: 2509\u20132515.","DOI":"10.1161\/01.CIR.102.20.2509"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, et al. Proposed diagnostic criteria for the Brugada syndrome: Consensus report. <i>Circulation<\/i> 2002; 106: 2514\u20132519.","DOI":"10.1161\/01.CIR.0000034169.45752.4A"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: Report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. <i>Circulation<\/i> 2005; 111: 659\u2013670.","DOI":"10.1161\/01.CIR.0000152479.54298.51"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ikeda T, Abe A, Yusu S, Nakamura K, Ishiguro H, Mera H, et al. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome. <i>J Cardiovasc Electrophysiol<\/i> 2006; 17: 602\u2013607.","DOI":"10.1111\/j.1540-8167.2006.00424.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Juang JJ, Horie M. Genetics of Brugada syndrome. <i>J Arrhythm<\/i> 2016; 32: 418\u2013425.","DOI":"10.1016\/j.joa.2016.07.012"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. <i>Nature<\/i> 1998; 392: 293\u2013296.","DOI":"10.1038\/32675"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Van Driest SL, Wells QS, Stallings S, Bush WS, Gordon A, Nickerson DA, et al. Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records. <i>JAMA<\/i> 2016; 315: 47\u201357.","DOI":"10.1001\/jama.2015.17701"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Crotti L, Marcou CA, Tester DJ, Castelletti S, Giudicessi JR, Torchio M, et al. Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: Implications for genetic testing. <i>J Am Coll Cardiol<\/i> 2012; 60: 1410\u20131418.","DOI":"10.1016\/j.jacc.2012.04.037"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bezzina C, Veldkamp MW, van den Berg MP, Postma AV, Rook MB, Viersma JW, et al. A single Na<sup>+<\/sup> channel mutation causing both long-QT and Brugada syndromes. <i>Circ Res<\/i> 1999; 85: 1206\u20131213.","DOI":"10.1161\/01.RES.85.12.1206"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. <i>Circ Res<\/i> 1999; 85: 803\u2013809.","DOI":"10.1161\/01.RES.85.9.803"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: Implications for arrhythmogenic susceptibility and Brugada\/long QT syndrome genetic testing. <i>Heart Rhythm<\/i> 2004; 1: 600\u2013607.","DOI":"10.1016\/j.hrthm.2004.07.013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, et al. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: Different incidences in familial and sporadic disease. <i>Hum Mutat<\/i> 2003; 21: 651\u2013652.","DOI":"10.1002\/humu.9144"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Neu A, Eiselt M, Paul M, Sauter K, Stallmeyer B, Isbrandt D, et al. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease. <i>Hum Mutat<\/i> 2010; 31: E1609\u2013E1621.","DOI":"10.1002\/humu.21302"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. <i>Circulation<\/i> 2007; 115: 442\u2013449.","DOI":"10.1161\/CIRCULATIONAHA.106.668392"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Antzelevitch C. In vivo human demonstration of phase 2 reentry. <i>Heart Rhythm<\/i> 2005; 2: 804\u2013806.","DOI":"10.1016\/j.hrthm.2005.05.013"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Postema PG, van Dessel PF, Kors JA, Linnenbank AC, van Herpen G, Ritsema van Eck HJ, et al. Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation. <i>J Am Coll Cardiol<\/i> 2010; 55: 789\u2013797.","DOI":"10.1016\/j.jacc.2009.11.033"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. <i>Circulation<\/i> 2001; 103: 710\u2013717.","DOI":"10.1161\/01.CIR.103.5.710"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJ, Verkerk AO, de Groot JR, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: A combined electrophysiological, genetic, histopathologic, and computational study. <i>Circulation<\/i> 2005; 112: 2769\u20132777.","DOI":"10.1161\/CIRCULATIONAHA.105.532614"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nademanee K, Raju H, de Noronha SV, Papadakis M, Robinson L, Rothery S, et al. Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome. <i>J Am Coll Cardiol<\/i> 2015; 66: 1976\u20131986.","DOI":"10.1016\/j.jacc.2015.08.862"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zhang J, Sacher F, Hoffmayer K, O\u2019Hara T, Strom M, Cuculich P, et al. Cardiac electrophysiologic substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients. <i>Circulation<\/i> 2015; 131: 1950\u20131959.","DOI":"10.1161\/CIRCULATIONAHA.114.013698"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Mizusawa Y, Morita H, Adler A, Havakuk O, Thollet A, Maury P, et al. Prognostic significance of fever-induced Brugada syndrome. <i>Heart Rhythm<\/i> 2016; 13: 1515\u20131520.","DOI":"10.1016\/j.hrthm.2016.03.044"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Shimizu W, Matsuo K, Kokubo Y, Satomi K, Kurita T, Noda T, et al. Sex hormone and gender difference: Role of testosterone on male predominance in Brugada syndrome. <i>J Cardiovasc Electrophysiol<\/i> 2007; 18: 415\u2013421.","DOI":"10.1111\/j.1540-8167.2006.00743.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. <i>J Cardiovasc Electrophysiol<\/i> 2000; 11: 1320\u20131329.","DOI":"10.1046\/j.1540-8167.2000.01320.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Batchvarov VN, Govindan M, Camm AJ, Behr ER. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome. <i>Heart Rhythm<\/i> 2009; 6: 625\u2013631.","DOI":"10.1016\/j.hrthm.2009.01.038"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Evain S, Briec F, Kyndt F, Schott JJ, Lande G, Albuisson J, et al. Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern. <i>Heart Rhythm<\/i> 2008; 5: 1561\u20131564.","DOI":"10.1016\/j.hrthm.2008.08.029"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. <i>Circulation<\/i> 2002; 105: 73\u201378.","DOI":"10.1161\/hc0102.101354"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Richter S, Sarkozy A, Paparella G, Henkens S, Boussy T, Chierchia GB, et al. Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: A diagnostic consensus criterion to be revised. <i>Eur Heart J<\/i> 2010; 31: 1357\u20131364.","DOI":"10.1093\/eurheartj\/ehq049"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Curcio A, Mazzanti A, Bloise R, Monteforte N, Indolfi C, Priori SG, et al. Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria. <i>J Cardiovasc Electrophysiol<\/i> 2016; 27: 937\u2013943.","DOI":"10.1111\/jce.12997"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Veltmann C, Papavassiliu T, Konrad T, Doesch C, Kuschyk J, Streitner F, et al. Insights into the location of type I ECG in patients with Brugada syndrome: Correlation of ECG and cardiovascular magnetic resonance imaging. <i>Heart Rhythm<\/i> 2012; 9: 414\u2013421.","DOI":"10.1016\/j.hrthm.2011.10.032"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Veltmann C, Wolpert C, Sacher F, Mabo P, Schimpf R, Streitner F, et al. Response to intravenous ajmaline: A retrospective analysis of 677 ajmaline challenges. <i>Europace<\/i> 2009; 11: 1345\u20131352.","DOI":"10.1093\/europace\/eup189"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Conte G, Sieira J, Sarkozy A, de Asmundis C, Di Giovanni G, Chierchia GB, et al. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: Incidence, clinical features, and prognosis. <i>Heart Rhythm<\/i> 2013; 10: 1869\u20131874.","DOI":"10.1016\/j.hrthm.2013.09.060"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Take Y, Morita H, Toh N, Nishii N, Nagase S, Nakamura K, et al. Identification of high-risk syncope related to ventricular fibrillation in patients with Brugada syndrome. <i>Heart Rhythm<\/i> 2012; 9: 752\u2013759.","DOI":"10.1016\/j.hrthm.2011.11.045"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Sacher F, Arsac F, Wilton SB, Derval N, Denis A, de Guillebon M, et al. Syncope in Brugada syndrome patients: Prevalence, characteristics, and outcome. <i>Heart Rhythm<\/i> 2012; 9: 1272\u20131279.","DOI":"10.1016\/j.hrthm.2012.04.013"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Benito B, Sarkozy A, Mont L, Henkens S, Berruezo A, Tamborero D, et al. Gender differences in clinical manifestations of Brugada syndrome. <i>J Am Coll Cardiol<\/i> 2008; 52: 1567\u20131573.","DOI":"10.1016\/j.jacc.2008.07.052"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Sieira J, Conte G, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, et al. Clinical characterisation and long-term prognosis of women with Brugada syndrome. <i>Heart<\/i> 2016; 102: 452\u2013458.","DOI":"10.1136\/heartjnl-2015-308556"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Probst V, Denjoy I, Meregalli PG, Amirault JC, Sacher F, Mansourati J, et al. Clinical aspects and prognosis of Brugada syndrome in children. <i>Circulation<\/i> 2007; 115: 2042\u20132048.","DOI":"10.1161\/CIRCULATIONAHA.106.664219"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kanter RJ, Pfeiffer R, Hu D, Barajas-Martinez H, Carboni MP, Antzelevitch C. Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay. <i>Circulation<\/i> 2012; 125: 14\u201322.","DOI":"10.1161\/CIRCULATIONAHA.111.054007"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Gonzalez Corcia MC, Sieira J, Sarkozy A, de Asmundis C, Chierchia GB, Hernandez Ojeda J, et al. Brugada syndrome in the young: An assessment of risk factors predicting future events. <i>Europace<\/i>, doi:10.1093\/europace\/euw206.","DOI":"10.1093\/europace\/euw206"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Conte G, Dewals W, Sieira J, de Asmundis C, Ciconte G, Chierchia GB, et al. Drug-induced brugada syndrome in children: Clinical features, device-based management, and long-term follow-up. <i>J Am Coll Cardiol<\/i> 2014; 63: 2272\u20132279.","DOI":"10.1016\/j.jacc.2014.02.574"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Kamakura T, Wada M, Nakajima I, Ishibashi K, Miyamoto K, Okamura H, et al. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome. <i>Circ Arrhythm Electrophysiol<\/i> 2015; 8: 785\u2013791.","DOI":"10.1161\/CIRCEP.114.002705"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Conte G, DE Asmundis C, Sieira J, Levinstein M, Chierchia GB, DI Giovanni G, et al. Clinical characteristics, management, and prognosis of elderly patients with Brugada syndrome. <i>J Cardiovasc Electrophysiol<\/i> 2014; 25: 514\u2013519.","DOI":"10.1111\/jce.12359"},{"key":"49","unstructured":"49. Postema PG, Tan HL, Wilde AA. Ageing and Brugada syndrome: Considerations and recommendations. <i>J Geriatr Cardiol<\/i> 2013; 10: 75\u201381."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Adler A, Rosso R, Chorin E, Havakuk O, Antzelevitch C, Viskin S. Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing. <i>Heart Rhythm<\/i> 2016; 13: 299\u2013310.","DOI":"10.1016\/j.hrthm.2015.08.038"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al. Natural history of Brugada syndrome: Insights for risk stratification and management. <i>Circulation<\/i> 2002; 105: 1342\u20131347.","DOI":"10.1161\/hc1102.105288"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Eckardt L, Kirchhof P, Schulze-Bahr E, Rolf S, Ribbing M, Loh P, et al. Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. <i>Eur Heart J<\/i> 2002; 23: 1394\u20131401.","DOI":"10.1053\/euhj.2002.3256"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. <i>Circulation<\/i> 2010; 121: 635\u2013643.","DOI":"10.1161\/CIRCULATIONAHA.109.887026"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Sroubek J, Probst V, Mazzanti A, Delise P, Hevia JC, Ohkubo K, et al. Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis. <i>Circulation<\/i> 2016; 133: 622\u2013630.","DOI":"10.1161\/CIRCULATIONAHA.115.017885"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Priori SG, Napolitano C, Brugada P, Brugada R, Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? <i>Circulation<\/i> 2005; 112: 279\u2013292.","DOI":"10.1161\/CIRCULATIONAHA.104.485326"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Yoshioka K, Amino M, Zareba W, Shima M, Matsuzaki A, Fujii T, et al. Identification of high-risk Brugada syndrome patients by combined analysis of late potential and T-wave amplitude variability on ambulatory electrocardiograms. <i>Circ J<\/i> 2013; 77: 610\u2013618.","DOI":"10.1253\/circj.CJ-12-0932"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, et al. Risk stratification in Brugada syndrome: Results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. <i>J Am Coll Cardiol<\/i> 2012; 59: 37\u201345.","DOI":"10.1016\/j.jacc.2011.08.064"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Miyamoto K, Yokokawa M, Tanaka K, Nagai T, Okamura H, Noda T, et al. Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome. <i>Am J Cardiol<\/i> 2007; 99: 53\u201357.","DOI":"10.1016\/j.amjcard.2006.07.062"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M, et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1\u2013V3. <i>Circ Arrhythm Electrophysiol<\/i> 2009; 2: 495\u2013503.","DOI":"10.1161\/CIRCEP.108.816892"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. <i>Circulation<\/i> 2005; 111: 257\u2013263.","DOI":"10.1161\/01.CIR.0000153267.21278.8D"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Giustetto C, Drago S, Demarchi PG, Dalmasso P, Bianchi F, Masi AS, et al. Risk stratification of the patients with Brugada type electrocardiogram: A community-based prospective study. <i>Europace<\/i> 2009; 11: 507\u2013513.","DOI":"10.1093\/europace\/eup006"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Casado-Arroyo R, Berne P, Rao JY, Rodriguez-Ma\u00f1ero M, Levinstein M, Conte G, et al. Long-term trends in newly diagnosed Brugada syndrome: Implications for risk stratification. <i>J Am Coll Cardiol<\/i> 2016; 68: 614\u2013623.","DOI":"10.1016\/j.jacc.2016.05.073"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Komatsu Y, et al. Outcome after implantation of cardioverter-defibrillator in patients with Brugada syndrome: A multicenter study\u2013part 2. <i>Circulation<\/i> 2013; 128: 1739\u20131747.","DOI":"10.1161\/CIRCULATIONAHA.113.001941"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Olde Nordkamp LR, Conte G, Rosenm\u00f6ller BR, Warnaars JL, Tan HL, Caputo ML, et al. Brugada syndrome and the subcutaneous implantable cardioverter-defibrillator. <i>J Am Coll Cardiol<\/i> 2016; 68: 665\u2013666.","DOI":"10.1016\/j.jacc.2016.05.058"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Rodr\u00edguez-Ma\u00f1ero M, Sacher F, de Asmundis C, Maury P, Lambiase PD, Sarkozy A, et al. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study. <i>Heart Rhythm<\/i> 2016; 13: 669\u2013682.","DOI":"10.1016\/j.hrthm.2015.10.038"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Shah AJ, Hocini M, Lamaison D, Sacher F, Derval N, Haissaguerre M. Regional substrate ablation abolishes Brugada syndrome. <i>J Cardiovasc Electrophysiol<\/i> 2011; 22: 1290\u20131291.","DOI":"10.1111\/j.1540-8167.2011.02054.x"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. <i>Circulation<\/i> 2011; 123: 1270\u20131279.","DOI":"10.1161\/CIRCULATIONAHA.110.972612"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Brugada J, Pappone C, Berruezo A, Vicedomini G, Manguso F, Ciconte G, et al. Brugada syndrome phenotype elimination by epicardial substrate ablation. <i>Circ Arrhythm Electrophysiol<\/i> 2015; 8: 1373\u20131381.","DOI":"10.1161\/CIRCEP.115.003220"},{"key":"69","unstructured":"69. Goldberger AL. Clinical electrocardiography: A simplified approach. <i>In<\/i>: Braunwald\u2019s heart disease: A textbook of cardiovascular medicine, 7th edn. Philadelphia: Saunders, 2005; 141\u2013142."},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Jervell A. The surdo-cardiac syndrome. <i>Eur Heart J<\/i> 1985; 6(Suppl D): 97\u2013102.","DOI":"10.1093\/eurheartj\/6.suppl_D.97"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K, et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. <i>Proc Natl Acad Sci USA<\/i> 2002; 99: 6210\u20136215.","DOI":"10.1073\/pnas.082121299"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Watanabe A, Fukushima Kusano K, Morita H, Miura D, Sumida W, Hiramatsu S, et al. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. <i>Eur Heart J<\/i> 2006; 27: 1579\u20131583.","DOI":"10.1093\/eurheartj\/ehl060"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita T, et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. <i>Heart Rhythm<\/i> 2007; 4: 695\u2013700.","DOI":"10.1016\/j.hrthm.2007.02.014"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Murakami M, Nakamura K, Kusano KF, Morita H, Nakagawa K, Tanaka M, et al. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation. <i>J Cardiovasc Pharmacol<\/i> 2010; 56: 389\u2013395.","DOI":"10.1097\/FJC.0b013e3181f03c2f"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Bouzeman A, Traulle S, Messali A, Extramiana F, Denjoy I, Narayanan K, et al. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine. <i>Europace<\/i> 2014; 16: 572\u2013577.","DOI":"10.1093\/europace\/eut279"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Sz\u00e9l T, Koncz I, Antzelevitch C. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome. <i>Heart Rhythm<\/i> 2013; 10: 1720\u20131727.","DOI":"10.1016\/j.hrthm.2013.07.047"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Minoura Y, Panama BK, Nesterenko VV, Betzenhauser M, Barajas-Mart\u00ednez H, Hu D, et al. Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome. <i>Heart Rhythm<\/i> 2013; 10: 1054\u20131062.","DOI":"10.1016\/j.hrthm.2013.03.011"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Veerman CC, Mengarelli I, Guan K, Stauske M, Barc J, Tan HL, et al. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities. <i>Sci Rep<\/i> 2016; 6: 30967.","DOI":"10.1038\/srep30967"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Okata S, Yuasa S, Suzuki T, Ito S, Makita N, Yoshida T, et al. Embryonic type Na+ channel \u03b2-subunit, SCN3B masks the disease phenotype of Brugada syndrome. <i>Sci Rep<\/i> 2016; 6: 34198.","DOI":"10.1038\/srep34198"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/3\/81_CJ-16-0971\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T07:31:15Z","timestamp":1498375875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/3\/81_CJ-16-0971\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-16-0971","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}